cagrilintide semaglutide combination phase 3 2024 CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1 Cagrilintide–semaglutide (CagriSema) versus semaglutide or

GLP-1 is secreted from L cells in the small intestine upon food stimuli including carbohydrates, lipids, proteins, amino acids, bile acids and short-chain fatty acids

GLP-1 analogs have been developed for the treatment of type II diabetes mellitus

While this study doesnt specifically look at eating disorders, it does suggest that people with eating disorders may be more likely to seek out GLP-1 medications

The results suggested that at week 12 after treatment discontinuation, there was no significant difference in weight regain between significant and not significant weight loss subgroup ( P = 0.99) (Additional file 2: Fig

Patients with higher baseline HbA1c levels often experience more dramatic initial improvements in blood glucose control, whilst those with more modest elevations may see smaller absolute changes

But we dont have a health care system that is structured to do that.